ESS More Cost-Efficient Than Biologics for CRSwNP in Spanish NHS
A 10-year economic analysis finds endoscopic sinus surgery offers better value than biologics for chronic rhinosinusitis with nasal polyps.
ECPR for OHCA in Singapore: Cost-Effective, but Sensitive to Transport Delays
A simulation-based analysis suggests ECPR for refractory OHCA in Singapore is cost-effective, though transport time significantly impacts its economic
FFR-Guided PCI Costs 30% Less Than Surgery for 3-Vessel Disease
A FAME 3 analysis shows fractional flow reserve-guided stenting yields equivalent quality-adjusted survival and faster functional recovery.
Delaying Infant Hepatitis B Vaccination Increases Infections and Costs
A Markov model of 3.6 million infants shows even a two-month delay in the birth dose raises mortality and healthcare expenditures.
Targeted Hepatitis B Birth Vaccination May Increase Neonatal Infections
A simulation of 3.6 million infants suggests replacing universal birth doses with targeted strategies could add 628 neonatal infections.
Everolimus Reduces Cancer Risk and Proves Cost-Effective in Liver Transplant
A cohort analysis shows adding everolimus to calcineurin inhibitors lowers malignancy risk but increases infection rates.
Indirect Expenses Account for 86 Percent of Trauma Resuscitation Costs
A time-driven activity-based costing analysis of 134 patients shows the average 17-minute resuscitation costs $3,628.
Alteplase Before Thrombectomy Loses Value After 170 Minutes
A 16-country analysis shows bridging therapy for large vessel occlusion is only cost-effective when initiated early after stroke onset.